Clinical trial
Gene Therapy in Treating Patients With Colon Cancer That Has Spread to the Liver
NCT00012155 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00012155 |
|---|---|
| Title | Gene Therapy in Treating Patients With Colon Cancer That Has Spread to the Liver |
| Official title | A Phase I, Open-Label, Dose-Escalating Study Of The Safety, Tolerability, And Anti-Tumor Activity Of A Single Intrahepatic Arterial Injection Of Genetically Engineered Herpes Simplex Virus, NV1020, In Subjects With Adenocarcinoma Of The Colon With Metastasis To The Liver |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Metastatic Cancer |
| Intervention type | Biological |
| Interventions | NV1020 |
| Start date | Oct 1, 2000 |
| Primary completion | Nov 1, 2002 |
| Completion | Dec 1, 2009 |
| First posted | Jun 9, 2003 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: